Pfizer CEO on moving beyond COVID vaccines to become a leader in cancer and obesity treatments
Pfizer CEO on moving beyond COVID vaccines to become a leader in cancer and obesity treatments
Business News
 Aug 13 2024    17:00 PM
 
 
Pfizer's CEO Albert Bourla is trying to reposition the global pharmaceutical giant for a post-pandemic world. Two years ago, Pfizer recorded an unprecedented $100 billion in annual sales from its COVID-19 vaccine and antiviral Paxlovid. Lofty expectations for…   Read More
Tags
Leave a comment
Comments ({{ storyCommentsCount }})
{{comment.name}}
{{comment.created | tsdate:'MMMM dd, yyyy'}}
{{comment.created | tsdate:'h:mm a'}}
{{comment.comment}}
{{replyComments.name}}
{{replyComments.created | tsdate:'MMMM dd, yyyy'}}
{{replyComments.created | tsdate:'h:mm a'}}
{{replyComments.comment }}

Related